Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Cell Death Discovery|June 11, 2024
The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancerMartina Dragonetti, Chiara Turco, Anna Benedetti, et al.Molecular Cell|December 30, 2008
PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loopEleonora Lapi, Silvia Di Agostino, Sara Donzelli, et al.Cell Death & Disease|February 6, 2024
ID4-dependent secretion of VEGFA enhances the invasion capability of breast cancer cells and activates YAP/TAZ via integrin β3-VEGFR2 interactionAnna Benedetti, Chiara Turco, Enzo Gallo, et al.Carcinogenesis|December 14, 2017
MicroRNA-128-3p-mediated depletion of Drosha promotes lung cancer cell migrationTania Frixa, Andrea Sacconi, Mario Cioce, et al.Carcinogenesis|November 11, 2017
MiRNA-513a-5p inhibits progesterone receptor expression and constitutes a risk factor for breast cancer: the hOrmone and Diet in the ETiology of breast cancer prospective studyPaola Muti, Sara Donzelli, Andrea Sacconi, et al.Nature Communications|July 21, 2019
β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancerPiera Tocci, Roberta Cianfrocca, Valeriana Di Castro, et al.Journal of Experimental & Clinical Cancer Research : CR|August 20, 2022
Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trialPaola Muti, Andrea Sacconi, Claudio Pulito, et al.Cell Death and Differentiation|November 24, 2020
Aberrant transcriptional and post-transcriptional regulation of SPAG5, a YAP-TAZ-TEAD downstream effector, fuels breast cancer cell proliferationValeria Canu, Sara Donzelli, Andrea Sacconi, et al.Breast Cancer Research : BCR|June 21, 2018
Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophagesSara Donzelli, Elisa Milano, Magdalena Pruszko, et al.Journal of Experimental & Clinical Cancer Research : CR|May 3, 2018
Serum miR-22 as potential non-invasive predictor of poor clinical outcome in newly diagnosed, uniformly treated patients with diffuse large B-cell lymphoma: an explorative pilot studyFrancesco Marchesi, Giulia Regazzo, Francesca Palombi, et al.Pageof 6